&Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.7M | Buy |
284,209
+50,731
| +22% | +$9.41M | 0.4% | 48 |
|
|
2025
Q1 | $47.9M | Buy |
233,478
+24,746
| +12% | +$5.08M | 0.51% | 41 |
|
|
2024
Q4 | $37.8M | Buy |
208,732
+89,331
| +75% | +$16.2M | 0.45% | 46 |
|
|
2024
Q3 | $23.5M | Buy |
119,401
+80,443
| +206% | +$15.9M | 0.45% | 50 |
|
|
2024
Q2 | $6.68M | Buy |
38,958
+24,170
| +163% | +$4.15M | 0.29% | 83 |
|
|
2024
Q1 | $2.69M | Buy |
14,788
+6,544
| +79% | +$1.19M | 0.37% | 53 |
|
|
2023
Q4 | $1.28M | Buy |
8,244
+2,557
| +45% | +$397K | 0.31% | 76 |
|
|
2023
Q3 | $848K | Buy |
5,687
+66
| +1% | +$9.84K | 0.4% | 48 |
|
|
2023
Q2 | $757K | Buy |
5,621
+388
| +7% | +$52.3K | 0.34% | 60 |
|
|
2023
Q1 | $834K | Sell |
5,233
-122
| -2% | -$19.4K | 0.4% | 50 |
|
|
2022
Q4 | $865K | Sell |
5,355
-44
| -0.8% | -$7.11K | 0.43% | 50 |
|
|
2022
Q3 | $725K | Sell |
5,399
-130
| -2% | -$17.5K | 0.42% | 56 |
|
|
2022
Q2 | $847K | Buy |
5,529
+99
| +2% | +$15.2K | 0.49% | 44 |
|
|
2022
Q1 | $880K | Buy |
5,430
+2,207
| +68% | +$358K | 0.49% | 45 |
|
|
2021
Q4 | $436K | Sell |
3,223
-475
| -13% | -$64.3K | 0.26% | 91 |
|
|
2021
Q3 | $399K | Buy |
3,698
+200
| +6% | +$21.6K | 0.25% | 90 |
|
|
2021
Q2 | $428K | Buy |
3,498
+745
| +27% | +$91.2K | 0.28% | 81 |
|
|
2021
Q1 | $298K | Sell |
2,753
-100
| -4% | -$10.8K | 0.22% | 107 |
|
|
2020
Q4 | $306K | Hold |
2,853
| – | – | 0.26% | 95 |
|
|
2020
Q3 | $250K | Buy |
2,853
+500
| +21% | +$43.8K | 0.25% | 93 |
|
|
2020
Q2 | $231K | Buy |
+2,353
| New | +$231K | 0.28% | 95 |
|
|
2020
Q1 | – | Sell |
-2,335
| Closed | -$207K | – | 145 |
|
|
2019
Q4 | $207K | Buy |
+2,335
| New | +$207K | 0.25% | 137 |
|